Cargando…
Response to Comment on: “Cardiovascular adverse events in patients with chronic lymphocytic leukemia receiving acalabrutinib monotherapy: pooled analysis of 762 patients”
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Fondazione Ferrata Storti
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9152971/ https://www.ncbi.nlm.nih.gov/pubmed/34788990 http://dx.doi.org/10.3324/haematol.2021.280310 |
| _version_ | 1784717753359269888 |
|---|---|
| author | Brown, Jennifer R. |
| author_facet | Brown, Jennifer R. |
| author_sort | Brown, Jennifer R. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9152971 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Fondazione Ferrata Storti |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-91529712022-06-13 Response to Comment on: “Cardiovascular adverse events in patients with chronic lymphocytic leukemia receiving acalabrutinib monotherapy: pooled analysis of 762 patients” Brown, Jennifer R. Haematologica Response Fondazione Ferrata Storti 2021-11-18 /pmc/articles/PMC9152971/ /pubmed/34788990 http://dx.doi.org/10.3324/haematol.2021.280310 Text en Copyright© 2022 Ferrata Storti Foundation https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution Noncommercial License (by-nc 4.0) which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited. |
| spellingShingle | Response Brown, Jennifer R. Response to Comment on: “Cardiovascular adverse events in patients with chronic lymphocytic leukemia receiving acalabrutinib monotherapy: pooled analysis of 762 patients” |
| title | Response to Comment on: “Cardiovascular adverse events in patients with chronic lymphocytic leukemia receiving acalabrutinib monotherapy: pooled analysis of 762 patients” |
| title_full | Response to Comment on: “Cardiovascular adverse events in patients with chronic lymphocytic leukemia receiving acalabrutinib monotherapy: pooled analysis of 762 patients” |
| title_fullStr | Response to Comment on: “Cardiovascular adverse events in patients with chronic lymphocytic leukemia receiving acalabrutinib monotherapy: pooled analysis of 762 patients” |
| title_full_unstemmed | Response to Comment on: “Cardiovascular adverse events in patients with chronic lymphocytic leukemia receiving acalabrutinib monotherapy: pooled analysis of 762 patients” |
| title_short | Response to Comment on: “Cardiovascular adverse events in patients with chronic lymphocytic leukemia receiving acalabrutinib monotherapy: pooled analysis of 762 patients” |
| title_sort | response to comment on: “cardiovascular adverse events in patients with chronic lymphocytic leukemia receiving acalabrutinib monotherapy: pooled analysis of 762 patients” |
| topic | Response |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9152971/ https://www.ncbi.nlm.nih.gov/pubmed/34788990 http://dx.doi.org/10.3324/haematol.2021.280310 |
| work_keys_str_mv | AT brownjenniferr responsetocommentoncardiovascularadverseeventsinpatientswithchroniclymphocyticleukemiareceivingacalabrutinibmonotherapypooledanalysisof762patients |